(Q40175029)

18 September 2017

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts (English)

1 reference

18 September 2017

Pascale Bonnafous

2

0 references

Lieve Naesens

object named as

Lieve Naesens

series ordinal

1

0 references

Erik De Clercq

object named as

Erik De Clercq

series ordinal

4

0 references

author name string

Henri Agut

series ordinal

3

1 reference

18 September 2017

1 December 2006

1 reference

Journal of Clinical Virology

18 September 2017

1 reference

18 September 2017

37 Suppl 1

1 reference

18 September 2017

S69-75

1 reference

In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Antiherpetic activity and mode of action of natural carrageenans of diverse structural types

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Update on human herpesvirus 6 biology, clinical features, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Quantitative analysis of human herpesvirus 6 cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

In search of effective anti-HHV-6 agents

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Influence of methisoprinol (isoprinosine) on HIV-infected human lymphocytes: in vitro immunological, virological, and ultrastructural studies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Resveratrol inhibition of varicella-zoster virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Mechanisms of action of ribavirin against distinct viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

1 reference

7 January 2021

Pharmacokinetic Analysis of Dextran Sulfate in Rats as Pertains to Its Clinical Usefulness for Therapy of HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Orally administered dextran sulfate is absorbed in HIV-positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Dextran sulfate is poorly absorbed after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Real-time PCR as a versatile tool for investigating the susceptibility of human herpesvirus 6 to antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Immunomodulatory agents for prophylaxis and therapy of infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Role of viral infections in the etiology of febrile seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Therapeutic Approaches to HHV-6 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Characterization of drug-specific T cells in lamotrigine hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Tromantadine: inhibitor of early and late events in herpes simplex virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Effects of chloroquine on viral infections: an old drug against today's diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Amantadine in Parkinson's disease: lymphocyte subsets and IL-2 secreting T cell precursor frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970015-4

7 January 2021

10.1016/S1386-6532(06)70015-4

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

17276373